GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review. Research Disease-a-month : DM June 12, 2026
A Narrative Review of the Psychiatric Aspects of Deep-Brain Stimulation for Movement Disorders: a Role for Consultation-Liaison Psychiatrists. Research Journal of the Academy of Consultation-Liaison Psychiatry June 12, 2026
Evaluation of diagnostic concordance between algorithms for Parkinson’s disease dementia News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents June 11, 2026
In Memoriam Regina Katzenschlager (06 June 1964–21 April 2026) News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents June 11, 2026
Prospective Multicenter Registry Study of Multiple System Atrophy in China Trial N/A Recruiting June 11, 2026
Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment Trial N/A Recruiting June 11, 2026
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease Trial Phase 2 Completed June 11, 2026
Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease Trial N/A Not yet recruiting June 11, 2026
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry Trial N/A Recruiting June 11, 2026
Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation Trial N/A Active, not recruiting June 11, 2026
Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders Trial Phase 3 Terminated June 11, 2026
Parkinson’s therapy mirivadelgat selected for multi-drug clinical trial News Parkinson's News Today – The Web's Daily Resource for Parkinson's News June 11, 2026